{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T13:10:45Z","timestamp":1789305045002,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijo.ijo_1602_19","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T03:13:07Z","timestamp":1590462787000},"page":"1095","source":"Crossref","is-referenced-by-count":14,"title":["All India Ophthalmological Society members' survey: Practice pattern of intravitreal anti-vascular endothelial growth factor injection"],"prefix":"10.4103","volume":"68","author":[{"given":"Namrata","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheepak","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraprasad","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.284809-1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ophtha.2016.10.036","article-title":"Trends of anti- vascular endothelial growth factor use in ophthalmology among privately insured and medicare advantage patients","author":"Parikh","year":"2017","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.284809-2","doi-asserted-by":"crossref","first-page":"e009006","DOI":"10.1136\/bmjopen-2015-009006","article-title":"Diffusi9on of anti-VEGF injections in the Portuguese national health system","author":"Marques","year":"2015","journal-title":"BMJ Open"},{"key":"key-10.4103\/0301-4738.284809-3","doi-asserted-by":"crossref","first-page":"e018289","DOI":"10.1136\/bmjopen-2017-018289","article-title":"A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015","author":"Holingworth","year":"2017","journal-title":"BMJ Open"},{"key":"key-10.4103\/0301-4738.284809-4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00006982-200410001-00002","article-title":"Evolving guidelines for intravitreous injections","author":"Aiello","year":"2004","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.284809-5","unstructured":"Available from: vrsi.in\/wp-content\/uploads\/2018\/02\/Avastin_Guidlines_Book.pdf. [Last accessed on 2019 Jul 26]."},{"key":"key-10.4103\/0301-4738.284809-6","unstructured":"Kumar A, Verma L, Aurora A, Saxena R. AIOS-VRSI guidelines for intravitreal injections. Available from: http:\/\/aios.org\/avguidelines.pdf. [Last accessed on 2019 Jul 26]."},{"key":"key-10.4103\/0301-4738.284809-7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000486145","article-title":"2018 update on Intravitreal Injections: Euretina expert consensus recommendations","author":"Grzybowski","year":"2018","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.284809-8","first-page":"43","article-title":"Asia-Pacific technology and trend survey 2016-2017","author":"Chhablani","year":"2019","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"key-10.4103\/0301-4738.284809-9","first-page":"820","article-title":"All India ophthalmological society members survey: 1.Cataract surgery antibiotic prophylaxis preferred practice pattern 2017","author":"Maharana","year":"2018","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.284809-10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajo.2010.08.039","article-title":"Survey of intravitreal injection techniques among retinal specialists in the United States","author":"Green-Simms","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.284809-11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.eye.6702232","article-title":"National survey of the technique of intravitreal triamcinolone injection in the United Kingdom","author":"Anijeet","year":"2007","journal-title":"Eye"},{"key":"key-10.4103\/0301-4738.284809-12","first-page":"141","article-title":"National survey of the ophthalmic use of anti-vascular endothelial growth factor drugs in Israel","author":"Waisbourd","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"key-10.4103\/0301-4738.284809-13","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2147\/OPTH.S117801","article-title":"Practice patterns of ophthalmologists administering intravitreal injections in Europe: A longitudinal survey","author":"Huang","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.284809-14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"key-10.4103\/0301-4738.284809-15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajo.2019.02.036","article-title":"Lessons learned from Avastin and OCT- the great, the good, the bad and the ugly: The LXXV Edward Jackson Memorial Lecture","author":"Rosenfeld","year":"2019","journal-title":"Am J Ophthalmology"},{"key":"key-10.4103\/0301-4738.284809-16","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1200\/JCO.2012.48.4857","article-title":"Contraindicated use of bevacizumab and toxicity in elderly patients with cancer","author":"Hershman","year":"2013","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0301-4738.284809-17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: A review of literature","author":"Falavarjani","year":"2013","journal-title":"Eye"},{"key":"key-10.4103\/0301-4738.284809-18","first-page":"1609","article-title":"Endophthalmitis following intravitreal anti-VEGF injections in ambulatory surgical centre facility: Incidence, management and outcome","author":"Mithal","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.284809-19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4103\/0301-4738.99855","article-title":"Cluster endophthalmitis following multiple intravitreal bevacizumab injections from a single use vial","author":"Khan","year":"2016","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.284809-20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/ceo.12489","article-title":"Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab","author":"Das","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.284809-21","first-page":"252","article-title":"A study on the contamination of injection bevacizumab on storage of multidose vials","author":"Saoji","year":"2018","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.284809-22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/bja\/aew305","article-title":"Glycaemic control during cataract surgery under loco-regional anaesthesia: A growing problem and we are none the wiser","author":"Kumar","year":"2016","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0301-4738.284809-23","unstructured":"Available from: www.aao.org>eyenet>article>community-eye-m-d-s- tackle-intra. [Last accessed on 2019 Aug 23]."},{"key":"key-10.4103\/0301-4738.284809-24","first-page":"44","article-title":"Nurse-led ranibizumab intravitreal injections in wet age-related macular degeneration: A literature review","author":"Gregg","year":"2107","journal-title":"Nurs Stand"},{"key":"key-10.4103\/0301-4738.284809-25","first-page":"734","article-title":"Implementation of a nurse-delivered intravitreal injection service","author":"Da","year":"2014","journal-title":"Eye"},{"key":"key-10.4103\/0301-4738.284809-26","first-page":"1897","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","author":"Martin","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.284809-27","first-page":"1399","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeration: One-year findings from the IVAN randomized trial","author":"Chakravarthy","year":"1012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.284809-28","doi-asserted-by":"crossref","first-page":"e005094","DOI":"10.1136\/bmjopen-2014-005094","article-title":"Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial","author":"Dakin","year":"2014","journal-title":"BMJ open"},{"key":"key-10.4103\/0301-4738.284809-29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajo.2018.04.008","article-title":"Estimating medicare and patient savings from the use of bevacizumab for the treatment of exudative age-related macular degeneration","author":"Rosenfeld","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.284809-30","unstructured":"Singh RP. ASRS global trends in retina. Available from: https:\/\/www.asrs.org\/.\/2018-global-trends-in-retina-survey-highlights-website.pdf. [Last accessed on 2019 Jul 28]."},{"key":"key-10.4103\/0301-4738.284809-31","unstructured":"19th Expert Committee on the Selection and Use of Essential Medicines. Available from: www.who.int\/selection_medicines\/committees\/.\/Bevacizumab. [Last accessed on 2019 Jul 28]."},{"key":"key-10.4103\/0301-4738.284809-32","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2147\/OPTH.S180393","article-title":"Biosimilars in ophthalmology: Is there a big change on the horizon?","author":"Sharma","year":"2018","journal-title":"Clin Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:53:04Z","timestamp":1786733584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1602_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"alternative-id":["284809"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1602_19","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}